MEDTECH & HEALTHTECH STARTUP 
STAGE (PRE-SERIES A)

Seeding Change: Challenges and Opportunities for Medtech and Healthtech Spin-Out Funding 

Medtech and Healthtech spin-outs seeking seed funding face a variety of obstacles in the current funding climate. Yet, with their academic expertise, cutting-edge research, and transformative technologies, there is an abundance of potential growth and innovation opportunities to help shape the healthcare industry. A panel of investors discuss how spin-outs can avoid getting stuck at the first hurdles. 

• How do investors assess the potential of early-stage spin-outs to overcome funding challenges and achieve sustained growth in a competitive market with less capital available? 
  
• What strategies do successful spin-outs employ to navigate the current funding environment?
  
• How do investors approach evaluating the market adoption potential and long-term viability of these ventures?
  

Pharma Collaborations: Failures to Successes

Within the scope of this overarching theme, we have the opportunity to delve into a multitude of subjects, including: 

• Examining the challenges in pharma-medtech/DTX startup partnerships. 
• A comparative exploration of what startups and pharma enterprises bring to the table, and what they seek from each other. 
• The investor's lens - A critical perspective on the dynamics of startup-pharma partnerships. 
• Navigating the path to the ideal collaborative allianc
  

Moderated: Anne Horgan, Partner, Cambridge Innovation Capital
Charles Conn, Co-Founder & Partner, Monograph Capital
Richard Cassidy, SVP, Rx+ Business Accelerator, Astellas 
Daria Gherghelas, Investor, Speedinvest

Drinks Reception

Close of Investival Showcase

Awards & Gala Dinner
- Separate ticket required
- Find out more